LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 61 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
| Q1 2022 | $1,000 | -90.9% | 862 | -81.6% | 0.00% | – |
| Q4 2021 | $11,000 | -64.5% | 4,697 | -30.0% | 0.00% | – |
| Q3 2021 | $31,000 | -31.1% | 6,706 | -33.5% | 0.00% | – |
| Q2 2021 | $45,000 | -79.8% | 10,091 | -67.1% | 0.00% | – |
| Q1 2021 | $223,000 | +125.3% | 30,676 | +137.7% | 0.00% | – |
| Q4 2020 | $99,000 | +59.7% | 12,908 | +88.4% | 0.00% | – |
| Q3 2020 | $62,000 | +44.2% | 6,851 | +33.3% | 0.00% | – |
| Q2 2020 | $43,000 | +207.1% | 5,140 | +84.3% | 0.00% | – |
| Q1 2020 | $14,000 | -44.0% | 2,789 | -19.4% | 0.00% | – |
| Q4 2019 | $25,000 | -47.9% | 3,459 | -21.6% | 0.00% | – |
| Q3 2019 | $48,000 | -5.9% | 4,414 | +13.4% | 0.00% | – |
| Q2 2019 | $51,000 | +13.3% | 3,894 | -16.0% | 0.00% | – |
| Q1 2019 | $45,000 | +32.4% | 4,634 | +38.1% | 0.00% | – |
| Q4 2018 | $34,000 | – | 3,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,470,000 | 0.65% |
| Orbimed Advisors | 6,466,783 | $31,946,000 | 0.54% |
| SAMLYN CAPITAL, LLC | 798,566 | $3,945,000 | 0.10% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 915,355 | $4,522,000 | 0.01% |
| IHT Wealth Management, LLC | 11,660 | $58,000 | 0.01% |
| FIDUCIARY TRUST CO | 37,998 | $188,000 | 0.01% |
| FRANKLIN RESOURCES INC | 700,000 | $3,458,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 13,700 | $68,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,249 | $11,000 | 0.00% |
| MANCHESTER FINANCIAL INC | 200 | $1,000 | 0.00% |